Improved LeverageDebt-to-equity falling to ~0.23 from ~0.77 materially lowers financial risk and increases strategic flexibility. A stronger balance sheet improves the firm's ability to fund capex, weather cyclical swings in specialty chemicals, pursue selective M&A, and maintain dividends over the next several quarters.
Recovering RevenueSustained top-line recovery—FY2026 revenue up ~3.6%—signals stable demand across inks, coatings and plastics end markets. Durable revenue growth across diverse industrial applications supports better capacity utilization, steadier margins if sustained, and the ability to reinvest in product development and customer channels.
Stronger Cash GenerationSolid operating cash flow and ~¥3.7B free cash flow in FY2026 show the business can convert earnings into cash, supporting capex, debt reduction, and shareholder returns. This cash-generation improvement enhances financial resilience and funds strategic initiatives over the medium term if consistency improves.